A phase 2 clinical trial of preoperative pembrolizumab and chemotherapy followed by adjuvant pembrolizumab in resectable locoregionally recurrent head and neck squamous cell carcinoma. This is an ASCO ...
Beyond the initial diagnosis: Epidemiological factors associated with second primary cancers among patients with head and neck squamous cell carcinoma (a SEER-based study). This is an ASCO Meeting ...
How much do I need to study to pass? Kimberly Overcast is an award-winning writer and fact-checker. She has ghostwritten political, health, and Christian nonfiction books for several authors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback